person · Reporting owner
Elliott Jeffrey Thomas
Disclosed activity across 5 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXACT SCIENCES CORPEXAS · Entity 56619 | Chief Financial Officer | April 30, 2024 | May 02, 2024 |
| EXAGEN INC.XGN · Entity 935 | Director | June 18, 2020 | July 02, 2020 |
| ICON PLCICLR · Entity 3439 | Director | August 10, 2026 | August 11, 2026 |
| Quanterix CorpQTRX · Entity 6649 | Director | August 19, 2026 | August 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXACT SCIENCES CORP
Report date April 30, 2024 · Filed May 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,795 |
Last balance in matching sequence
After 2024-05-01 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2024-04-30 · Grant · Acquired 291 · Balance 11,224 F1: Represents additional shares of common stock received upon settlement of a performance share unit award on April 30, 2024. F2: In addition to the shares of Common Stock reported on this Form 4, which total 13,380 shares, Mr. Elliott also holds, in the aggregate, an additional 134,437 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Row 2 · 2024-04-30 · Grant · Acquired 707 · Balance 11,931 F3: Represents shares of common stock purchased through Employee Stock Purchase Plan. F2: In addition to the shares of Common Stock reported on this Form 4, which total 13,380 shares, Mr. Elliott also holds, in the aggregate, an additional 134,437 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Row 3 · 2024-05-01 · Sale · Disposed 136 · Balance 11,795 F4: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units. F2: In addition to the shares of Common Stock reported on this Form 4, which total 13,380 shares, Mr. Elliott also holds, in the aggregate, an additional 134,437 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectHeld in 401(k) Plan | 1,585 |
Reported balance
Holding disclosure · report date 2024-04-30 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,585 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents additional shares of common stock received upon settlement of a performance share unit award on April 30, 2024.
F2: In addition to the shares of Common Stock reported on this Form 4, which total 13,380 shares, Mr. Elliott also holds, in the aggregate, an additional 134,437 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F3: Represents shares of common stock purchased through Employee Stock Purchase Plan.
F4: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units.
EXAGEN INC.
Report date June 18, 2020 · Filed July 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option(right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.00 · Expires 2030-06-17 | Direct | 9,000 |
Reported balance
After 2020-06-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-06-18 · Grant · Acquired 9,000 · Balance 9,000 F1: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
ICON PLC
Report date August 10, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 1,324 |
Reported balance
After 2026-08-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-10 · Grant · Acquired 1,324 · Balance 1,324 F1: Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting. F2: These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting.
F2: These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027.
Quanterix Corp
Report date August 19, 2026 · Filed August 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,345 |
Reported balance
After 2026-08-19 transaction · row 1
1 source rowRow 1 · 2026-08-19 · Exercise / conversion · Acquired 3,955 · Balance 15,345 F1: Restricted stock units convert into common stock on a one-for-one basis. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 4,075 |
Reported balance
After 2026-08-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-19 · Exercise / conversion · Disposed 3,955 · Balance 4,075 F2: On August 19, 2024, the reporting person was granted 11,985 restricted stock units, vesting 33%, 33%, and 34% on the first, second, and third anniversaries of the grant date, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: On August 19, 2024, the reporting person was granted 11,985 restricted stock units, vesting 33%, 33%, and 34% on the first, second, and third anniversaries of the grant date, respectively.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SERA PROGNOSTICS, INC.
Report date June 04, 2026 · Filed June 04, 2026
Section 16 reporting ended · disclosed 2026-06-04. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 19, 2026 Filed Aug 20, 2026 20:59 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionRestricted Stock Unit · Derivative | 3,955 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001689757-26-000005 · primarydocument.xml · derivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,075 Underlying: Common Stock · 3,955 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On August 19, 2024, the reporting person was granted 11,985 restricted stock units, vesting 33%, 33%, and 34% on the first, second, and third anniversaries of the grant date, respectively. F2 · derivative.expiration_date: On August 19, 2024, the reporting person was granted 11,985 restricted stock units, vesting 33%, 33%, and 34% on the first, second, and third anniversaries of the grant date, respectively. Read SEC document |
| August 19, 2026 Filed Aug 20, 2026 20:59 UTC | Quanterix Corp QTRX · Entity 6649 | Exercise / conversionCommon Stock | 3,955 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001689757-26-000005 · primarydocument.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| August 10, 2026 Filed Aug 11, 2026 20:27 UTC | ICON PLC ICLR · Entity 3439 | GrantRestricted Share Units · Derivative | 1,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-055732 · wk-form4_1786480024.xml · derivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,324 Underlying: Ordinary Shares · 1,324 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting. F2 · derivative.exercise_date: These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027. F2 · derivative.expiration_date: These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027. F2 · derivative.underlying: These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027. Read SEC document |
| January 02, 2026 Filed Jan 14, 2026 16:01 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 23,372 | $0.00 | $0.00 |
DisclosureSEC source: 0001689757-26-000001 · primarydocument.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,792 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on January 2, 2027 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 31,402 restricted stock units. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 21:18 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | GrantStock Option (right to buy) · Derivative | 47,363 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0000950170-25-043347 · ownership.xml · derivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,363 Underlying: Class A Common Stock · 47,363 shares Expires 2035-03-20 F2 · derivative.exercise_date: These stock options vest over three years as follows: 1/36 of the original grant amount vests in monthly installments for three years following the vesting commencement date, which is March 20, 2025, subject to the Reporting Person continuing to provide services to the issuer. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 21:18 UTC | SERA PROGNOSTICS, INC. SERA · Entity 304 | GrantClass A Common Stock | 30,534 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-043347 · ownership.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,534 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). These RSUs vest over three years as follows: 1/36 of the original grant amount vests in monthly installments for three years following the vesting commencement date, which is March 20, 2025, subject to the Reporting Person continuing to provide services to the issuer. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:49 UTC | Quanterix Corp QTRX · Entity 6649 | GrantStock Option (Right to Buy) · Derivative | 15,821 | $0.00 Strike: $10.76 | $0.00 |
DisclosureSEC source: 0001562180-25-000203 · primarydocument.xml · derivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,821 Underlying: Common Stock · 15,821 shares Expires 2035-01-02 F3 · shares: Represents non-qualified stock option to purchase 15,821 shares of common stock granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:49 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 7,435 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-000203 · primarydocument.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,420 F1 · shares: Represents restricted stock units that vest as to 100% of the shares on December 31, 2025 granted pursuant to the Quanterix Corporation Amended and Restated Non-Employee Director Compensation Policy. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. F2 · balance_after: Includes 19,420 restricted stock units. Read SEC document |
| August 19, 2024 Filed Aug 21, 2024 20:29 UTC | Quanterix Corp QTRX · Entity 6649 | GrantStock Option (right to buy) · Derivative | 25,908 | $0.00 Strike: $13.35 | $0.00 |
DisclosureSEC source: 0001562180-24-006436 · primarydocument.xml · derivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,908 Underlying: Common Stock · 25,908 shares Expires 2034-08-19 F3 · derivative.exercise_date: The option vests as to one-third of the shares on August 19, 2025, and the remaining two-thirds of the shares vest monthly thereafter over two years in 24 successive equal installments. Read SEC document |
| August 19, 2024 Filed Aug 21, 2024 20:29 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 11,985 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-006436 · primarydocument.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,985 F1 · shares: Represents shares of stock issuable on vesting of restricted stock units. The restricted stock units vest as to one-third of shares on each of August 19, 2025, August 19, 2026 and August 19, 2027. F2 · balance_after: Includes 11,985 restricted stock units. Read SEC document |
| May 01, 2024 Filed May 2, 2024 19:00 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 136 | $60.15 | $8,180.40 |
DisclosureSEC source: 0000950170-24-052386 · ownership.xml · nonDerivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,795 F4 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units. F2 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 13,380 shares, Mr. Elliott also holds, in the aggregate, an additional 134,437 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| April 30, 2024 Filed May 2, 2024 19:00 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 707 | $30.02 | $21,224.14 |
DisclosureSEC source: 0000950170-24-052386 · ownership.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,931 F3 · shares: Represents shares of common stock purchased through Employee Stock Purchase Plan. F2 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 13,380 shares, Mr. Elliott also holds, in the aggregate, an additional 134,437 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| April 30, 2024 Filed May 2, 2024 19:00 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 291 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-052386 · ownership.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,224 F1 · shares: Represents additional shares of common stock received upon settlement of a performance share unit award on April 30, 2024. F2 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 13,380 shares, Mr. Elliott also holds, in the aggregate, an additional 134,437 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| March 01, 2024 Filed Mar 4, 2024 20:40 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 2,412 | $59.32 | $143,079.84 |
DisclosureSEC source: 0001209191-24-004239 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,933 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 12,518 shares, Mr. Elliott also holds, in the aggregate, an additional 134,437 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 20:40 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 5,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004239 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,876 Underlying: Common Stock · 5,291 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 29, 2024. The restricted stock units vest in four equal annual installments from the grant date. F5 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 29, 2024. The restricted stock units vest in four equal annual installments from the grant date. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 20:40 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 5,291 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004239 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,345 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| February 27, 2024 Filed Feb 28, 2024 19:36 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 2,710 | $56.89 | $154,171.90 |
DisclosureSEC source: 0001209191-24-004079 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,054 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 9,639 shares, Mr. Elliott also holds, in the aggregate, an additional 139,728 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 19:36 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantRestricted Stock Units · Derivative | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004079 · doc4.xml · derivative · entry 5 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,750 Underlying: Common Stock · 4,750 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: These restricted stock units fully vest on February 28, 2025. F6 · derivative.expiration_date: These restricted stock units fully vest on February 28, 2025. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 19:36 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 5,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004079 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,401 Underlying: Common Stock · 5,701 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 26, 2024. The restricted stock units vest in four equal annual installments from the grant date. F5 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 26, 2024. The restricted stock units vest in four equal annual installments from the grant date. Read SEC document |
| February 26, 2024 Filed Feb 28, 2024 19:36 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 5,701 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004079 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,764 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 20:01 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,351 | $59.78 | $80,762.78 |
DisclosureSEC source: 0001209191-24-003921 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,063 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 6,648 shares, Mr. Elliott also holds, in the aggregate, an additional 140,678 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 21, 2024 Filed Feb 22, 2024 19:38 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,493 | $61.50 | $91,819.50 |
DisclosureSEC source: 0001209191-24-003869 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,703 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 5,288 shares, Mr. Elliott also holds, in the aggregate, an additional 140,678 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 21, 2024 Filed Feb 23, 2024 20:01 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 2,711 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003921 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,414 F1 · shares: Represents shares of common stock received upon settlement of a performance share unit award on February 21, 2024. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 19:38 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 3,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003869 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,112 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award granted on February 19, 2021 that vests in four equal annual installments from the grant date. F5 · derivative.expiration_date: Represents a restricted stock unit award granted on February 19, 2021 that vests in four equal annual installments from the grant date. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 19:38 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 3,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003869 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| February 15, 2024 Filed Feb 16, 2024 18:24 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,888 | $61.43 | $115,979.84 |
DisclosureSEC source: 0001209191-24-003465 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,084 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 14, 2024. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 3,397 shares, Mr. Elliott also holds, in the aggregate, an additional 143,791 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 18:24 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 3,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003465 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,972 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award that fully vested on February 14, 2024. F5 · derivative.expiration_date: Represents a restricted stock unit award that fully vested on February 14, 2024. Read SEC document |
| February 14, 2024 Filed Feb 16, 2024 18:24 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 3,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003465 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 16:08 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 30,210 | $82.92 | $2,505,013.20 |
DisclosureSEC source: 0001209191-23-047025 · doc4.xml · nonDerivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F2 · shares: The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into on May 24, 2023 and previously disclosed in the Company's Quarterly Report on Form 10-Q for the quarter ended June 30, 2023. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 1,313 shares, Mr. Elliott also holds, in the aggregate, an additional 147,763 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| May 01, 2023 Filed Aug 23, 2023 16:08 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 709 | $30.02 | $21,284.18 |
DisclosureSEC source: 0001209191-23-047025 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,210 F1 · shares: Represents shares of common stock purchased through Employee Stock Purchase Plan. Read SEC document |
| February 28, 2023 Filed Mar 1, 2023 17:27 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 4,233 | $61.12 | $258,720.96 |
DisclosureSEC source: 0001209191-23-014261 · doc4.xml · nonDerivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,241 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 27, 2023. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 30,508 shares, Mr. Elliott also holds, in the aggregate, an additional 147,763 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 17:27 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 3,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014261 · doc4.xml · derivative · entry 6 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 27, 2023. The restricted stock units vested in four equal annual installments beginning on February 26, 2020. F6 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 27, 2023. The restricted stock units vested in four equal annual installments beginning on February 26, 2020. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 17:27 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014261 · doc4.xml · derivative · entry 5 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,102 Underlying: Common Stock · 5,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 27, 2023. The restricted stock units vest in four equal annual installments beginning on February 25, 2023. F5 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 27, 2023. The restricted stock units vest in four equal annual installments beginning on February 25, 2023. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 17:27 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 3,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014261 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 17:27 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 5,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-014261 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,037 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 17:23 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantRestricted Stock Units · Derivative | 21,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-013787 · doc4.xml · derivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,167 Underlying: Common Stock · 21,167 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: These restricted stock units vest in four equal annual installments beginning on February 29, 2024. F3 · derivative.expiration_date: These restricted stock units vest in four equal annual installments beginning on February 29, 2024. Read SEC document |
| February 22, 2023 Filed Feb 23, 2023 16:20 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,430 | $62.72 | $89,689.60 |
DisclosureSEC source: 0001209191-23-012166 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,337 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 21, 2023. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 25,604 shares, Mr. Elliott also holds, in the aggregate, an additional 135,733 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 16:20 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 3,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012166 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,225 Underlying: Common Stock · 3,112 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 21, 2023. The restricted stock units vest in four equal annual installments beginning on February 19, 2022. F5 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 21, 2023. The restricted stock units vest in four equal annual installments beginning on February 19, 2022. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 16:20 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 3,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012166 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,767 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 17:07 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,866 | $65.59 | $122,390.94 |
DisclosureSEC source: 0001209191-23-010135 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,655 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 14, 2023. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 23,922 shares, Mr. Elliott also holds, in the aggregate, an additional 138,845 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 17:07 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 3,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-010135 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,972 Underlying: Common Stock · 3,972 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 14, 2023. The restricted stock units vest in four equal annual installments beginning on February 14, 2021. F5 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 14, 2023. The restricted stock units vest in four equal annual installments beginning on February 14, 2021. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 17:07 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 3,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-010135 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| February 13, 2023 Filed Feb 14, 2023 17:42 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,158 | $64.55 | $74,748.90 |
DisclosureSEC source: 0001209191-23-009305 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,549 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units on February 10, 2023. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 17:42 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionPerformance Stock Units · Derivative | 2,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009305 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,579 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each Performance Share Unit represents a right to receive one share of common stock. F5 · derivative.exercise_date: On February 22, 2022, Mr. Elliott agreed to accept performance vesting stock units ("PSUs") in lieu of one-half of his bonus opportunity for 2022. The amount of the PSUs that ultimately vested was equal to the percentage of the bonus opportunity that was paid to bonus plan participants based on the achievement of corporate goals established for such plan. F5 · derivative.expiration_date: On February 22, 2022, Mr. Elliott agreed to accept performance vesting stock units ("PSUs") in lieu of one-half of his bonus opportunity for 2022. The amount of the PSUs that ultimately vested was equal to the percentage of the bonus opportunity that was paid to bonus plan participants based on the achievement of corporate goals established for such plan. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 17:42 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 2,579 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-009305 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon settlement of a performance share unit award (the "PSU Award") on February 10, 2023, which is described further in Footnote 5 to this Form 4. Read SEC document |
| May 02, 2022 Filed Aug 23, 2023 16:08 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 260 | $47.41 | $12,326.60 |
DisclosureSEC source: 0001209191-23-047025 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,501 F1 · shares: Represents shares of common stock purchased through Employee Stock Purchase Plan. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 17:22 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 4,050 | $76.69 | $310,594.50 |
DisclosureSEC source: 0001209191-22-014929 · doc4.xml · nonDerivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,128 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 28, 2022. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 20,318 shares, Mr. Elliott also holds, in the aggregate, an additional 142,818 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 17:22 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 3,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014929 · doc4.xml · derivative · entry 6 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,436 Underlying: Common Stock · 3,437 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 28, 2022. The restricted stock units vest in four equal annual installments beginning on February 26, 2020. F6 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 28, 2022. The restricted stock units vest in four equal annual installments beginning on February 26, 2020. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 17:22 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 5,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014929 · doc4.xml · derivative · entry 5 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award that partially vested on February 28, 2022. The restricted stock units vest in four equal annual installments beginning on February 27, 2019. F5 · derivative.expiration_date: Represents a restricted stock unit award that partially vested on February 28, 2022. The restricted stock units vest in four equal annual installments beginning on February 27, 2019. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 17:22 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 3,437 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-014929 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,178 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.